I have spent 11 years in pharma commercial operations and managed markets. I’ve sat through thousands of hours of conference presentations. I have a running spreadsheet on my desktop—it isn’t pretty, but it lists every conference I’ve attended, who I actually met, and whether the conversation moved the needle on a contract or a formulary hurdle.
If I hear one more person say a conference was "great for networking" without naming a single person they spoke to who controls a budget or a clinical policy, I’m going to walk out. Let’s stop pretending that walking a trade show floor is a strategy. If you want to solve oncology access barriers, you need to be in rooms where the economics of care delivery are the primary topic, not the backdrop.
ACCC: Where Community Oncology Programs Actually Live
The ACCC National Oncology Conference is non-negotiable for anyone serious about community oncology programs. Unlike national medical congresses that focus solely on clinical efficacy, ACCC digs into the operational hell of delivering that care. If you are trying to understand why your buy-and-bill process is stalling in a mid-sized network, this is where you go to find out why.
At ACCC, you aren't just talking to KOLs; you are talking to the practice administrators https://highstylife.com/which-events-actually-move-the-needle-on-formulary-strategy/ who deal with prior authorization denials and the pharmacy directors who track drug wastage. They aren't interested in your brand deck; they are interested in how your hub services—or lack thereof—are causing them administrative burden.
What to look for at ACCC
- Operational friction points: Look for sessions on staff-to-patient ratios for authorization processing. The "Monday Morning" Test: Can you take a specific feedback point regarding your patient support program back to your internal team on Monday? If not, you’re in the wrong session. Payer pushback: These folks know exactly which payers are cutting reimbursement rates in real-time. Listen more than you pitch.
AMCP: Payer Expectations and the Formulary Gauntlet
The Academy of Managed Care Pharmacy (AMCP) is where the rubber meets the road regarding managed care strategy. If your oncology asset is hitting HTA (Health Technology Assessment) pressure or struggling with restrictive step edits, you need to be here. This is not the place for clinical fluff. This is the place for pharmacoeconomic data and value-based contracting discussions.
Managed care directors attend AMCP to see how products fit into their population health models. They are looking for evidence generation that proves long-term cost offsets. If your value proposition is just "better efficacy," you will lose here. You need to prove formulary execution—how easy is it for them to manage your drug in their system without creating a backlog of HEOR data for payer engagement appeals?
AMCP Strategy Notes
Always keep an eye on the digital tools companies are demoing in the exhibit hall. Many vendors are showing off tools for real-time evidence generation. When you look at these booths, check their digital hygiene. If they can’t even manage basic UI elements like a compliant Cookie Law Info plugin correctly on their site, how can you trust their data handling? It sounds petty, but in my experience, the attention to detail in their digital interface mirrors the attention to detail in their data output.
THMA: Navigating the Health System C-Suite
The Health Management Academy (THMA) is the only place I’ve found that consistently pulls in health system executives who make the final decisions on large-scale oncology adoption. If your market access challenge isn't just about getting on a list, but about getting your product integrated into the clinical pathways of a massive IDN (Integrated Delivery Network), THMA is your venue.
The barrier here is often "pricing and affordability" viewed through the lens of a system’s bottom line. These executives aren't just thinking about the cost of the drug; they are thinking about the cost of administration, infusion center utilization, and the downstream impact of side effect management.
Comparing the Conference ROI
I maintain this table to ensure I don't waste my budget or my team's time. Use it to map your objectives to the right environment.
Conference Primary Focus Ideal Contact Core Value ACCC Community Oncology Programs Practice Administrator / RN Lead Operational process barriers AMCP Managed Care Strategy Payer Pharmacy Director Formulary & HTA positioning THMA Health System Adoption Health System C-Suite Pathway integration & economics
Pricing, Affordability, and HTA Pressure
Market access is no longer just about "getting on the list." It is about defending your price against HTA pressure. Whether you are at an AMCP panel or a private roundtable at an ACCC event, the conversation has shifted from "Is it effective?" to "Is the health system infrastructure capable of absorbing the cost and the complexity of this drug?"
When you attend these sessions, stop asking, "How do we get this in front of them?" Start asking, "What is the economic barrier to adoption in a community setting?" If your drug requires complex storage, or if the reimbursement process requires three different departments to talk to each other, you have a delivery problem, not a clinical problem. These conferences allow you to pressure-test your solutions to those delivery problems.
What Would I Do Differently on Monday?
The "What would I do differently on Monday?" test is the only metric that matters. When you leave one of these events, you should be able to sit down at your desk and change one thing. Maybe it’s a slide in your deck that you realized wasn't landing with payers at AMCP. Maybe it’s a change in your support program’s instruction manual based on a complaint you heard at ACCC. If you didn't learn something that triggers a concrete, actionable change, the conference was an expensive vacation.
Key Takeaways for Your Next Trip
Stop the "Synergy" talk: No one cares about your internal cross-functional alignment. They care about their own barriers to care. Vet the digital footprint: If a vendor at a congress is pushing a "digital transformation" tool for evidence generation, look for basic compliance and site-level UX consistency. It reveals their level of rigor. Document the "Who": My spreadsheet note-taking is the difference between a successful fiscal year and a wasted travel budget. Write down names, titles, and—most importantly—the specific pain point they mentioned. Prioritize Community Oncology: If you are ignoring the ACCC National Oncology Conference, you are missing the most critical feedback loop in the industry right now.The industry is moving toward higher evidence standards and lower administrative tolerance. If you aren't using these conferences to gather real-world intelligence on where your access strategy is actually breaking, you’re just paying for flight miles and hotel rooms.